Champlain Investment Partners, LLC Integra Lifesciences Holdings Corp Transaction History

Champlain Investment Partners, LLC

$15.8 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$33.4 - $45.2 $8.42 Million - $11.4 Million	252,015 Added 10.35%	2,687,972 $95.3 Million
Q4 2023 Feb 13, 2024	SELL	$34.21 - $44.59 $98,251 - $128,062	-2,872 Reduced 0.12%	2,435,957 $106 Million
Q3 2023 Nov 13, 2023	SELL	$37.8 - $45.97 $55.3 Million - $67.2 Million	-1,462,894 Reduced 37.49%	2,438,829 $93.1 Million
Q2 2023 Aug 11, 2023	SELL	$37.95 - $58.98 $48.2 Million - $74.9 Million	-1,269,936 Reduced 24.56%	3,901,723 $160 Million
Q1 2023 May 12, 2023	SELL	$52.61 - $60.49 $4.62 Million - $5.31 Million	-87,865 Reduced 1.67%	5,171,659 $297 Million
Q4 2022 Feb 13, 2023	SELL	$42.17 - $58.6 $4.22 Million - $5.86 Million	-100,031 Reduced 1.87%	5,259,524 $295 Million
Q3 2022 Nov 14, 2022	SELL	$42.28 - $57.17 $3.94 Million - $5.33 Million	-93,260 Reduced 1.71%	5,359,555 $227 Million
Q2 2022 Aug 12, 2022	SELL	$53.86 - $66.52 $7.16 Million - $8.84 Million	-132,915 Reduced 2.38%	5,452,815 $295 Million
Q1 2022 May 12, 2022	SELL	$62.86 - $69.24 $6.86 Million - $7.55 Million	-109,107 Reduced 1.92%	5,585,730 $359 Million
Q4 2021 Feb 10, 2022	SELL	$62.47 - $73.25 $2.02 Million - $2.37 Million	-32,400 Reduced 0.57%	5,694,837 $381 Million
Q3 2021 Nov 12, 2021	SELL	$64.97 - $76.19 $50.9 Million - $59.6 Million	-782,793 Reduced 12.02%	5,727,237 $392 Million
Q2 2021 Aug 12, 2021	SELL	$66.79 - $76.63 $1.28 Million - $1.47 Million	-19,145 Reduced 0.29%	6,510,030 $444 Million
Q1 2021 May 13, 2021	BUY	$62.63 - $71.15 $4.43 Million - $5.03 Million	70,710 Added 1.09%	6,529,175 $451 Million
Q4 2020 Feb 12, 2021	BUY	$43.31 - $66.55 $8.12 Million - $12.5 Million	187,445 Added 2.99%	6,458,465 $419 Million
Q3 2020 Nov 13, 2020	BUY	$43.33 - $51.72 $2.73 Million - $3.25 Million	62,910 Added 1.01%	6,271,020 $296 Million
Q2 2020 Aug 13, 2020	BUY	$41.42 - $55.57 $368,223 - $494,017	8,890 Added 0.14%	6,208,110 $292 Million
Q1 2020 May 14, 2020	BUY	$36.67 - $61.04 $4.86 Million - $8.09 Million	132,560 Added 2.19%	6,199,220 $277 Million
Q4 2019 Feb 13, 2020	BUY	$55.73 - $62.49 $21.6 Million - $24.2 Million	387,900 Added 6.83%	6,066,660 $354 Million
Q3 2019 Nov 14, 2019	SELL	$53.29 - $64.59 $4.34 Million - $5.26 Million	-81,470 Reduced 1.41%	5,678,760 $341 Million
Q2 2019 Aug 13, 2019	BUY	$46.45 - $55.85 $13.3 Million - $16 Million	286,410 Added 5.23%	5,760,230 $322 Million
Q1 2019 May 14, 2019	BUY	$42.97 - $57.33 $3.34 Million - $4.46 Million	77,845 Added 1.44%	5,473,820 $305 Million
Q4 2018 Feb 13, 2019	BUY	$42.62 - $64.51 $2.28 Million - $3.44 Million	53,390 Added 1.0%	5,395,975 $243 Million
Q3 2018 Nov 13, 2018	BUY	$57.63 - $65.87 $12.2 Million - $13.9 Million	211,115 Added 4.11%	5,342,585 $352 Million
Q2 2018 Aug 13, 2018	BUY	$54.05 - $67.23 $7.24 Million - $9 Million	133,875 Added 2.68%	5,131,470 $331 Million
Q1 2018 May 14, 2018	BUY	$46.55 - $57.38 $16.4 Million - $20.2 Million	351,520 Added 7.57%	4,997,595 $277 Million
Q4 2017 Feb 12, 2018	BUY	$46.22 - $51.77 $5.1 Million - $5.71 Million	110,355 Added 2.43%	4,646,075 $222 Million
Q3 2017 Nov 13, 2017	BUY	$47.8 - $53.63 $217 Million - $243 Million	4,535,720	4,535,720 $229 Million

Others Institutions Holding IART

# of Institutions

255

Shares Held

75.5M

Call Options Held

10.7K

Put Options Held

57.7K

Black Rock Inc. New York, NY

11.3M
Shares

$201 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.77M
Shares

$139 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.5M
Shares

$98.3 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$75.3 Million
0.26% of portfolio
Wellington Management Group LLP Boston, MA

3.89M
Shares

$69.5 Million
0.02% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.49B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account